PHAR - Pharming Group N.V. - ADR
IEX Last Trade
7.68
-0.100 -1.302%
Share volume: 2,459
Last Updated: Fri 30 Aug 2024 08:48:25 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.78
-0.10
-1.29%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
1.72%
1 Month
-1.66%
3 Months
-13.89%
6 Months
-30.72%
1 Year
-38.94%
2 Year
-33.39%
Key data
Stock price
$7.68
DAY RANGE
N/A - N/A
52 WEEK RANGE
$6.65 - $16.71
52 WEEK CHANGE
-$0.35
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Sijmen de Vries
Region: US
Website: https://www.pharming.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.pharming.com/
Employees: 0
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news